EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Reporting Frequency of Antipsychotics‐Induced Tardive Dyskinesia and Other Extrapyramidal Symptoms: Analysis Based on a Spontaneous Reporting System Database in Japan

Yosuke Saga iD, Hiroshi Horio, Chih-Lin Chiang, Akihide Wakamatsu

Neuropsychopharmacology Reports · 2025

DOI: 10.1002/npr2.70049 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Neuropsychopharmacology Reports, 2025. Verfasst von Yosuke Saga und 3 weiteren Autor:innen. Beteiligte Einrichtung: Medical Affairs Department, Johnson & Johnson, Tokyo, Japan. Hauptthemen laut MEDLINE: Antipsychotic Agents, Tardive Dyskinesia, Adverse Drug Reaction Reporting Systems, Basal Ganglia Diseases. Die Arbeit nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Johnson & Johnson, Japan, Johnson and Johnson.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

First‐ and second‐generation antipsychotics (FGAs and SGAs, respectively) with dopamine‐antagonizing properties may cause involuntary movement‐related adverse drug reactions (ADRs). However, the risk in the Japanese population is not well characterized. In this study, we analyzed spontaneous ADR reports from the Japanese Adverse Drug Event Report (JADER) database and evaluated the reporting odds ratios (RORs) of tardive dyskinesia (TD) and other extrapyramidal symptoms (EPS) associated with antipsychotics. SGAs were evaluated both as a whole class and as subgroups based on their primary pharmacological mode of action. From 1 April 2011 to 31 March 2020, 1 197 065 ADRs, including 760 TD and 6059 EPS cases, were identified for this study. By calculating RORs, risk signals were detected with both FGAs and SGAs for TD and EPS compared with non‐antipsychotics, with an ROR (95% confidence interval (CI)) of 153.9 (125.64–188.34) with FGAs for TD and 95.3 (80.61–112.65) with SGAs total for TD. No risk signals were detected for SGAs total data or any SGA subgroups versus FGAs. The ROR (95% CI) with SGAs total versus FGAs for TD was 0.62 (0.51–0.75), for dyskinesia: 0.55 (0.42–0.72), and for parkinsonism: 0.43 (0.35–0.52), showing that SGAs were associated with lower reporting frequency versus FGAs, but not for akathisia and dystonia. In conclusion, both FGAs and SGAs were associated with risks for TD and EPS compared with non‐antipsychotics in the Japanese population, and SGAs total or all SGA subgroups showed no risk signals compared with FGAs.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antipsychotic AgentsTardive DyskinesiaAdverse Drug Reaction Reporting SystemsBasal Ganglia DiseasesDyskinesia, Drug-InducedHumansJapanMaleFemaleMiddle AgedDatabases, FactualAdultAgedYoung AdultAdolescentAged, 80 and over

Stichwörter der Autor:innen

Japanese Adverse Drug Event Report (JADER) databaseantipsychoticsextrapyramidal symptomreporting odds ratiotardive dyskinesia

Substanzen

Antipsychotic Agents

Autor:innen und Institutionen

  • Medical Affairs Department, Johnson & Johnson, Tokyo, Japan.

ORCID-Profile: Yosuke Saga

Förderung

  • Johnson & Johnson, Japan
  • Johnson and Johnson

Zitieren

APA

Saga, Y., Horio, H., Chiang, C. L., & Wakamatsu, A. (2025). Reporting Frequency of Antipsychotics‐Induced Tardive Dyskinesia and Other Extrapyramidal Symptoms: Analysis Based on a Spontaneous Reporting System Database in Japan. Neuropsychopharmacology Reports. https://doi.org/10.1002/npr2.70049

Vancouver

Saga Y, Horio H, Chiang CL, Wakamatsu A. Reporting Frequency of Antipsychotics‐Induced Tardive Dyskinesia and Other Extrapyramidal Symptoms: Analysis Based on a Spontaneous Reporting System Database in Japan. Neuropsychopharmacology Reports. 2025. doi:10.1002/npr2.70049

BibTeX
@article{Saga2025,
  author = {Saga, Yosuke and Horio, Hiroshi and Chiang, Chih-Lin and Wakamatsu, Akihide},
  title = {Reporting Frequency of Antipsychotics‐Induced Tardive Dyskinesia and Other Extrapyramidal Symptoms: Analysis Based on a Spontaneous Reporting System Database in Japan},
  journal = {Neuropsychopharmacology Reports},
  year = {2025},
  doi = {10.1002/npr2.70049}
}
Kostenlos starten →